b2 10 1
b2 10 1
b2 10 1
2 COMPLICATIONS OF PREGNANCY
2.10 ABNORMALITIES OF LIE / PRESENTATION
Date Issued: August 1993
Date Revised: April 2012
Review Date: April 2015
Authorised by: OGCCU
Review Team: OGCCU
5.
6.
DPMS
Ref: 5179
ELUSCS for a singleton breech at term has been shown to reduce perinatal or neonatal
2, 3
mortality rates and serious neonatal morbidity rate in the first 6 weeks of life.
Long-term follow-up at 2 years showed neurological infant outcomes do not differ by planned
3, 4
mode of delivery even in the presence of serious short term neonatal morbidity.
ELUSCS is not associated with substantially better or worst outcomes for women 2 years after
6
birth when compared to planned vaginal singleton breech birth at term.
All women with a singleton breech presentation with no contra-indications to the procedure
should be offered an ECV. Success rates for ECV are approximately 40% in nulliparous
1
women and 60% in multiparae women.
A woman attending a low-risk midwifery antenatal clinic, and who is found to have a breech
presentation at 35-36 weeks gestation shall be referred for obstetric medical review prior to 37
weeks gestation.
Careful case selection and labour management in a modern obstetrical setting may achieve a
3
level of safety similar to ELUSCS. Planned vaginal singleton breech birth is an option for
women who have no maternal or fetal contra-indications to this mode of delivery.
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 1 of 4
7.
The mode of birth for pre-term breech presentation is made based according to individual
clinical situations, and the decision is made after discussion with the team Consultant and the
woman.
ANTENATAL MANAGEMENT
Breech presentation may require different options for management:
ECV
Refer women with a breech presentation between 35-36 weeks gestation for medical obstetric
review as near as possible to 36 weeks gestation.
If there are no contra-indications the woman should be offered an ECV between 36-37 weeks
gestation. An ECV at 34-36 may be performed with Consultant approval. The woman should
be advised of the risk for preterm birth associated with performing ECV at this gestation.
Prior to booking an ECV explanation about the procedure shall be given including risks, sideeffects, and outcomes.
Depending on the maternal decision regarding mode of delivery obtain written consent:
ELUSCS on the MR295 Generic consent form
ECV on the MR295.75 Consent form for external cephalic version
See Clinical Guidelines, Section B 2.10.2 External Cephalic Version for detailed information
about the procedure and contraindications.
Clinical Guidelines, Section B 2.10.2.1 Maternal Fetal Assessment Unit Quick Reference
Guide External Cephalic Version.
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 2 of 4
The woman has completed a consent form after counselling regarding risks and
outcomes of a breech birth compare to an ELUSCS.
1, 3
1, 3
or macrosomia
3-6
1
1, 10
Note: for criteria and management of a vaginal breech birth see Clinical Guideline,
Section B 2.10.3 Breech Labour and Birth Management
5.
6.
7.
8.
9.
Royal College of obstetricians and Gynaecologists. The management of breech presentation. RCOG
Green-top Guideline No 20b. 2006.
Hannah ME, Hannah WJ, Hewson SA, et al. Planned caesarean section versus planned vaginal birth for
breech presentation at term: a randomised multicentre trial. The Lancet. 2000;356:1375-83.
Society of Obstetricians and Gynaecologist of Canada. Vaginal Delivery of Breech Presentation. Journal
of Obstetric Gynaecology of Canada. 2009(June):557-66.
Whyte H, Hannah ME, Saigal S, et al. Outcomes of children at 2 years after planned cesarean birth
versus planned vaginal birth for breech presentation at term: the International Randomised Term Breech
Trial. American Journal of Obstetrics and Gynecology. 2004;191:864-71.
Goffinet F, Carayol M, Foidart J-M, et al. Is planned vaginal delivery for breech presentation at term still
an option? Results of an observational prospective survey in France and Belgium. American Journal of
Obstetrics and Gynecology. 2006;194:1002-11.
Hannah ME, Whyte H, Hannah W. Maternal outcomes at 2 years after planned cesarean section versus
planned vaginal birth for breech presentation at term: The International Randomized Term Breech Trial.
American Journal of Obstetrics and Gynecology. 2004;191:917-27.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Planned breech
deliveries at erm. RANZCOG College statement C-Obs 11. 2007.
Rietberg CC, Elferink-Stinkens PM, Visser GHA. The effect of the Term Breech Trial on medical
intervention behaviour and neonatal outcome in the netherlands: an analysisi of 35,453 term breech
infants. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112:205-9.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of
term breech presentation. College Statement C-Obs 11. 2009.
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 3 of 4
10.
Taillefer C, Dube J. Single Breech at Term: Two Continents, Two Approaches. JOGC.
2010(March):238-43.
11.
Hofmeyr GJ, Kulier R. External cephalic version for breech presentation at term. The Cochrane
Database of Systematic reviews. 2011(1).
Grootscholten K, Kok M, Oei G, et al. External Cephalic Version-Related Risks A Meta-analysis.
Obstetrics & Gynecology. 2008;112(5):1143-51.
Collins S, Ellaway P, Harrington D, et al. The complications of external cephalic version: results from 805
consecutive attempts. BJOG: an International Journal of Obstetrics and Gynaecology.
2007;114:636-38.
Hutton EK, Hannah ME, Ross SJ. The Early External Cephalic Version (ECV) 2 Trial: an international
multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG: an International
Journal of Obstetrics and Gynaecology. 2011;118:564-77.
12.
13.
14.
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 4 of 4
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 5 of 4
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 6 of 4
Date Issued:
Date Revised: April 2012
Review Date: April 2015
Written by:/Authorised by: OGCCU
Review Team: OGCCU
DPMS Ref: 5179
Section B
Clinical Guidelines
King Edward Memorial Hospital
Perth Western Australia
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 7 of 4
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 8 of 4
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 9 of 4